Jump to content
RemedySpot.com

UPDATE - LDN AWARENESS WEEK 19-25 OCT 2009 - Congress Presentation

Rate this topic


Guest guest

Recommended Posts

Great news from Battle...

Battle, PA-C, advised he recently received confirmation that his LDN

Presentation has been accepted for this year's World Congress on Antiaging

Medicine and Regenerative and Biomedical Technologies being held in

December.

There are 6000 physicians attending this meeting, making it the largest

meeting of its kind in the world, and all 6000 attendees will receive a DVD

of all the Congress lectures.

's photo and abstract about LDN will be published in an annual text

book that describes the proceedings, and the textbook will be sent to

universities and libraries around the world.

The A4M membership consists of approx 22,000 clinicians internationally.

estimates the direct exposure will be about 25,000 clinicians across

105 different countries.

Details follow:

LDN AWARENESS UPDATE

(1) WHO - Battle, PA-C (Physician Assistant), Broomfield, Colorado

(2) TOPIC - 'LOW DOSE NALTREXONE AND ITS REGULATORY EFFECTS ON CANCER CELL

GROWTH AND AUTOIMMUNE DISEASE'

The general sub-topics will be:

(a) The Endorphin and Metenkephalin physiology in immune function

(B) Effects of Low Dose Naltrexone and Opiate Growth Factor in changing the

immune response.

© Clinical studies and appropriate clinical applications that LDN has

been used .

(d) How patients use LDN.

(3) WHERE - World Congress on Antiaging Medicine and Regenerative and

Biomedical Technologies held at the Mandalay resort in Las Vegas, Nevada

(www.worldhealth.net)

(4) WHEN - Dec 12 2009

(5) GENERAL ACCESS - Following the Congress, will place his powerpoint

presentation on the internet so others can view it. As the Congress will be

captured on video, he's hoping he's be able to obtain a copy to share over

the internet.

Congratulations !

We're all looking forward to your update after the Congress.

All my best,

Cris

Cris Kerr

'Advocate for the value of patient testimony'

Freely Shared LDN Resource Book: 'Those Who Suffer Much, Know Much'

http://www.ldnresearchtrustfiles.co.uk/docs/2009.pdf

Ex Administrator - 'Case Health - Health Success Stories' website

(May 2001 to May 2009 - casehealth.com.au & casehealth.com)

" The good we secure for ourselves is precarious and uncertain

until it is secured for all of us and incorporated into our common life. "

Jane Addams

Link to comment
Share on other sites

What truely amazing news! Well done to and many thanks to him too for

spreading the word in the best way.

Bev

>

> Great news from Battle...

>

> Battle, PA-C, advised he recently received confirmation that his LDN

> Presentation has been accepted for this year's World Congress on Antiaging

> Medicine and Regenerative and Biomedical Technologies being held in

> December.

>

> There are 6000 physicians attending this meeting, making it the largest

> meeting of its kind in the world, and all 6000 attendees will receive a DVD

> of all the Congress lectures.

>

> 's photo and abstract about LDN will be published in an annual text

> book that describes the proceedings, and the textbook will be sent to

> universities and libraries around the world.

>

> The A4M membership consists of approx 22,000 clinicians internationally.

> estimates the direct exposure will be about 25,000 clinicians across

> 105 different countries.

>

> Details follow:

>

> LDN AWARENESS UPDATE

>

> (1) WHO - Battle, PA-C (Physician Assistant), Broomfield, Colorado

>

> (2) TOPIC - 'LOW DOSE NALTREXONE AND ITS REGULATORY EFFECTS ON CANCER CELL

> GROWTH AND AUTOIMMUNE DISEASE'

>

> The general sub-topics will be:

> (a) The Endorphin and Metenkephalin physiology in immune function

> (B) Effects of Low Dose Naltrexone and Opiate Growth Factor in changing the

> immune response.

> © Clinical studies and appropriate clinical applications that LDN has

> been used .

> (d) How patients use LDN.

>

> (3) WHERE - World Congress on Antiaging Medicine and Regenerative and

> Biomedical Technologies held at the Mandalay resort in Las Vegas, Nevada

> (www.worldhealth.net)

>

> (4) WHEN - Dec 12 2009

>

> (5) GENERAL ACCESS - Following the Congress, will place his powerpoint

> presentation on the internet so others can view it. As the Congress will be

> captured on video, he's hoping he's be able to obtain a copy to share over

> the internet.

>

> Congratulations !

>

> We're all looking forward to your update after the Congress.

>

> All my best,

> Cris

>

> Cris Kerr

> 'Advocate for the value of patient testimony'

> Freely Shared LDN Resource Book: 'Those Who Suffer Much, Know Much'

> http://www.ldnresearchtrustfiles.co.uk/docs/2009.pdf

> Ex Administrator - 'Case Health - Health Success Stories' website

> (May 2001 to May 2009 - casehealth.com.au & casehealth.com)

>

> " The good we secure for ourselves is precarious and uncertain

> until it is secured for all of us and incorporated into our common life. "

> Jane Addams

>

Link to comment
Share on other sites

that is great news.they are a group of open minded doctors

>

> Great news from Battle...

>

> Battle, PA-C, advised he recently received confirmation that his LDN

> Presentation has been accepted for this year's World Congress on Antiaging

> Medicine and Regenerative and Biomedical Technologies being held in

> December.

>

> There are 6000 physicians attending this meeting, making it the largest

> meeting of its kind in the world, and all 6000 attendees will receive a DVD

> of all the Congress lectures.

>

> 's photo and abstract about LDN will be published in an annual text

> book that describes the proceedings, and the textbook will be sent to

> universities and libraries around the world.

>

> The A4M membership consists of approx 22,000 clinicians internationally.

> estimates the direct exposure will be about 25,000 clinicians across

> 105 different countries.

>

> Details follow:

>

> LDN AWARENESS UPDATE

>

> (1) WHO - Battle, PA-C (Physician Assistant), Broomfield, Colorado

>

> (2) TOPIC - 'LOW DOSE NALTREXONE AND ITS REGULATORY EFFECTS ON CANCER CELL

> GROWTH AND AUTOIMMUNE DISEASE'

>

> The general sub-topics will be:

> (a) The Endorphin and Metenkephalin physiology in immune function

> (B) Effects of Low Dose Naltrexone and Opiate Growth Factor in changing the

> immune response.

> © Clinical studies and appropriate clinical applications that LDN has

> been used .

> (d) How patients use LDN.

>

> (3) WHERE - World Congress on Antiaging Medicine and Regenerative and

> Biomedical Technologies held at the Mandalay resort in Las Vegas, Nevada

> (www.worldhealth.net)

>

> (4) WHEN - Dec 12 2009

>

> (5) GENERAL ACCESS - Following the Congress, will place his powerpoint

> presentation on the internet so others can view it. As the Congress will be

> captured on video, he's hoping he's be able to obtain a copy to share over

> the internet.

>

> Congratulations !

>

> We're all looking forward to your update after the Congress.

>

> All my best,

> Cris

>

> Cris Kerr

> 'Advocate for the value of patient testimony'

> Freely Shared LDN Resource Book: 'Those Who Suffer Much, Know Much'

> http://www.ldnresearchtrustfiles.co.uk/docs/2009.pdf

> Ex Administrator - 'Case Health - Health Success Stories' website

> (May 2001 to May 2009 - casehealth.com.au & casehealth.com)

>

> " The good we secure for ourselves is precarious and uncertain

> until it is secured for all of us and incorporated into our common life. "

> Jane Addams

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...